New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...
Faron Pharma expands bexmarilimab programme in solid tumours with a randomized phase I/II BEXAR IIT in metastatic soft-tissue sarcoma: Turku, Finland Thursday, January 29, 2026, 1 ...
New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...
Study conducted in a collaboration between MEDSIR and University Hospital Vall d'Hebron to evaluate bexmarilimab plus standard-of-care doxorubicin in a high-unmet-need frontline setting. TURKU, FI / ...
Study conducted in a collaboration between MEDSIR and University Hospital Vall d'Hebron to evaluate bexmarilimab plus standard-of-care doxorubicin in a high-unmet-need frontline setting. TURKU, FI / A ...
The Intraoperative Radiation Therapy Market offers opportunities driven by rising cancer cases, especially in breast oncology. The market is boosted by technological advancements in portable systems, ...
Abstract: A common limitation of autonomous tissue manipulation in robotic minimally invasive surgery (MIS) is the absence of force sensing and control at the tool level. Recently, our team has ...
Agenus Inc. ( Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that France’s National Agency for Medicines and Health Products Safety (ANSM) has approved an updated national ...
LEXINGTON, Mass., January 12, 2026--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that France’s National Agency for Medicines and Health Products ...
The development of non-invasive probes with significant penetration depth is crucial for quickly characterizing biological tissues during surgical resection specimens, ensuring the full removal of ...
Background: Survival prediction using radiomics and deep learning (DL) has shown promise, but its utility for predicting local recurrence among patients with primary retroperitoneal sarcoma (RPS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results